MarketInOut Stock Screener Log In | Sign Up
 

aTyr Pharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/12/2026 16:00
aTyr Pharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization67.67 mln
Float95.61 mln
Earnings Date05/13/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.97
Highly reliable

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.18
Very low leverage

ROE

-101
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

aTyr Pharma is a San Diego-based clinical-stage biotech company focused on treating serious lung and inflammatory diseases. Its most advanced drug candidate, efzofitimod, is currently being tested in multiple clinical trials for pulmonary sarcoidosis and related lung conditions, with a partnership in place for its development and commercialization in Japan. The company also has earlier-stage programs targeting liver disease and fibrosis, and its work is rooted in research into a class of proteins that play a broader biological role than scientists originally recognized.

Key Fundamentals

EPS-0.80
ROE-101
RPS0.00
ROIC-510
ROA-74.83
EBITDA, mln-76.07
EV / EBITDA-0.14
EV / EBIT-0.14
Revenue, mln0.19
EV / Revenue56.32

Financial Strength

Altman Z-Score-9.11
Piotroski F-Score 3 / 9
Beneish M-Score-3.97
Short Ratio21.96
Short % of Float23.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -37.05% 1 / 100   
1 Month -34.58% 3 / 100   
2 Months -44.78% 6 / 100   
6 Months -35.1% 16 / 100   
1 Year -83.84% 5 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us